TecniGen Ramipril/Hidroclorotiazida

TecniGen is a prominent pharmaceutical brand specialized in generic medications (EFG - Equivalente Farmacéutico Genérico) within the Spanish healthcare market. This specific product is a combination of Ramipril (an ACE inhibitor) and Hydrochlorothiazide (a diuretic), used to treat high blood pressure.

The brand TecniGen was originally established in Spain to provide cost-effective medical solutions. While the brand has its roots in Spain, it is currently part of the Zentiva group, one of Europe's largest manufacturers of generic medicines. Consequently, manufacturing occurs across various European facilities, primarily within Spain for the local market and in pharmaceutical hubs like the Czech Republic. Following its acquisition by Advent International, Zentiva operates as a pan-European platform with headquarters in Prague.